Angioedema (AE) occurring during ACE inhibitor therapy (ACEi-AE) is a rare complication
involving between 0.1 and 0.7% of treated patients. AE can also complicate other …

Angiotensin-converting enzyme (ACE) inhibitors are used primarily in the treatment of
hypertension, heart failure, and in the acute phase of myocardial infarction. Lisinopril [N2 …

Introduction The presence or absence of cirrhosis in patients with chronic hepatitis C virus
(HCV) infection influences the type and duration of antiviral therapy. Non-invasive markers …

Interventions: The ACE inhibitor was used for arterial hypertension on a daily basis for the
past 5 years. Patient developed airway obstruction requiring intubation. Standard therapy …

In 1977 the US Food and Drug Administration (FDA) recommended that females of
childbearing potential be excluded from Phase I and Phase II clinical trials, which led to a …

Angioedema is an immunologic disorder that results in the rapid progression of localized
subcutaneous or submucosal swelling that typically affects the face, lips, tongue, and …

Introduction Angiotensin converting enzyme (ACE) inhibitors are a leading class of
antihypertensives, which are a well-documented cause of angioedema related to …

• WHO global target of HCV elimination by 2030 depends on access to testing and treatment
with direct acting antivirals1• Linkage to care following HCV diagnosis is a gap in the HCV …

Angiotensin-converting enzyme inhibitor induced angioedema (AIIA) can vary from mild to
life-threatening. A vast majority of cases of AIIA occur within a month of starting an …

The aetiology and epidemiology of angioneurotic edema (ANE), the impact of socio-
demographic factors on the course and manifestations of the disease have not been fully …